Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Accuray: Fiscal Q1 Earnings Snapshot AP - Wed Nov 5, 3:51PM CST

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 1.0200 (-0.97%)
Accuray Reports Fiscal 2026 First Quarter Financial Results PR Newswire - Wed Nov 5, 3:05PM CST

MADISON, Wis. , Nov. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025.

ARAY : 1.0200 (-0.97%)
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules PR Newswire - Fri Oct 31, 3:03PM CDT

MADISON, Wis. , Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new...

ARAY : 1.0200 (-0.97%)
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025 PR Newswire - Tue Oct 28, 6:35AM CDT

MADISON, Wis. , Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference...

ARAY : 1.0200 (-0.97%)
Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth PR Newswire - Mon Oct 20, 8:20AM CDT

Industry Veteran Steve La Neve Named Chief Executive Officer  Suzanne Winter to Retire as President and CEO Company Appoints Steven F. Mayer as Transformation Board Sponsor...

ARAY : 1.0200 (-0.97%)
Biomarker-Driven Therapies And AI Technologies Transform $312B Precision Oncology Market BayStreet.ca - Fri Oct 17, 8:31AM CDT

Issued on behalf of GT Biopharma, Inc. VANCOUVER – Baystreet.ca News Commentary – Biomarker-driven approaches enhance the likelihood of identifying optimal patient populations and streamline...

CORT : 84.66 (+1.18%)
ARAY : 1.0200 (-0.97%)
KURA : 11.98 (+0.08%)
GTBP : 0.6298 (+3.59%)
TNGX : 9.90 (+3.45%)
Accuray Announces Milestone for Cancer Patients in Melbourne, Australia with First SBRT Treatments Using the CyberKnife® System PR Newswire - Wed Oct 8, 6:35AM CDT

5D Clinics and Joint Venture Partner Icon Group Make Strides in Delivering on Commitment to Increasing Access to World-class Radiation Treatments for More Communities Across Australia.

ARAY : 1.0200 (-0.97%)
Accuray and the University of Wisconsin-Madison Announce Memorandum of Understanding to Advance Online Adaptive Radiotherapy in Support of Improving Cancer Patient Care PR Newswire - Tue Sep 30, 6:35AM CDT

MADISON, Wis. , Sept. 30, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced today the...

ARAY : 1.0200 (-0.97%)
Accuray Up Slightly on Unveiling Stellar Solution Baystreet - Fri Sep 26, 8:52AM CDT

Accuray Incorporated (NASDAQ: ARAY) announced today that the company is advancing its legacy of leadership ...

ARAY : 1.0200 (-0.97%)
Accuray Launches All-in-One Radiotherapy Solution With Advanced Capabilities Designed to Set a New Standard in Cancer Care PR Newswire - Fri Sep 26, 6:35AM CDT

New Solution Provides an Unprecedented Set of Tools, Empowering Clinical Teams With Choice and Flexibility to Deliver Adaptive Care—Tailoring Radiotherapy to Each Patient's Unique Needs

ARAY : 1.0200 (-0.97%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025? Barchart - Thu Dec 4, 6:30PM CST
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot